Tourette Syndrome Treatment Market - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2021 - 2026)

 

Tourette syndrome is just a rare and severe neurological disorder that causes tics. Tic is just a repetitive involuntary movements, sudden, no rhythmic motor movements. It occurs because of the mutations of the SLITRK1 gene, which plays a significant role in development of nerve cells. This syndrome usually occurs on the list of individuals of age between 2-15 years. You will find four types of tics: motor tics (uncontrolled body movements), vocal tics (outburst of sound), simple tics (includes few elements of body) and complex tics (contains several elements of body). Tourette's syndrome relates to other additional neurobehavioral problems like impulsivity, problems with reading and writing, obsessive compulsive symptoms. It can be treated with neuroleptics; haloperidol and pimozide are largely used medicines for Tourette syndrome. Other medications such as guanfacine and clonidine are helpful to treat the severity of tics.

Some of the major players operating in the global Tourette Syndrome Treatment Market include Neurocrine Biosciences Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Apotex, Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals Limited and Eli Lilly Pharmaceuticals.